Distinct Physiological Effects of Dopamine D4 Receptors on Prefrontal Cortical Pyramidal Neurons and Fast-Spiking Interneurons

Cerebral Cortex

Volumn 26, Issue 1, 2016, Pages 180-191

  Zhong, Ping ^a,b   Yan, Zhen ^a,b  

^a UNIVERSITY AT BUFFALO   (United States)

^b VA WESTERN NEW YORK HEALTHCARE SYSTEM   (United States)

Author keywords

D4 receptors; dopamine; interneurons; prefrontal cortex; synaptically driven excitability

Indexed keywords

6,7 DINITRO 2,3 QUINOXALINEDIONE; CHLORPHENIRAMINE MALEATE PLUS PHENYLEPHRINE; DOPAMINE; DOPAMINE 4 RECEPTOR; N [4 (2 CYANOPHENYL) 1 PIPERAZINYLMETHYL] 3 METHYLBENZAMIDE; PARVALBUMIN; PHENCYCLIDINE; VANOXERINE;

ACTION POTENTIAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ELECTROPHYSIOLOGY; CONTROLLED STUDY; ENZYME ACTIVATION; FAST SPIKING INTERNEURON; INTERNEURON; MOUSE; NERVE CELL EXCITABILITY; NERVE EXCITABILITY; NONHUMAN; PHYSIOLOGICAL PROCESS; POPULATION; POSTSYNAPTIC MEMBRANE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; SCHIZOPHRENIA; SYNAPTIC POTENTIAL; SYNAPTIC TRANSMISSION; ANIMAL; DRUG EFFECTS; EXCITATORY POSTSYNAPTIC POTENTIAL; METABOLISM; PATCH CLAMP TECHNIQUE; PHYSIOLOGY; PROCEDURES; SYNAPSE; TRANSGENIC MOUSE;

ACTION POTENTIALS; ANIMALS; DOPAMINE; EXCITATORY POSTSYNAPTIC POTENTIALS; INTERNEURONS; MICE, TRANSGENIC; PATCH-CLAMP TECHNIQUES; PREFRONTAL CORTEX; PYRAMIDAL CELLS; RECEPTORS, DOPAMINE D4; SYNAPSES; SYNAPTIC TRANSMISSION;

EID: 84959913144     PISSN: 10473211     EISSN: 14602199     Source Type: Journal    
DOI: 10.1093/cercor/bhu190     Document Type: Article

References (72)

1. Adams B, Moghaddam B. 1998. Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine. J Neurosci. 18: 5545-5554.
2. Akbarian S, Kim JJ, Potkin SG, Hagman JO, Tafazzoli A, Bunney WE Jr, Jones EG. 1995. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch Gen Psychiatry. 52: 258-266.
3. Arvanov VL, Wang RY. 1999. Clozapine, but not haloperidol, prevents the functional hyperactivity of n-methyl-d-aspartate receptors in rat cortical neurons induced by subchronic administration of phencyclidine. J Pharmacol Exp Ther. 289: 1000-1006.
4. Beasley CL, Zhang ZJ, Patten I, Reynolds GP. 2002. Selective deficits in prefrontal cortical GABAergic neurons in schizophrenia defined by the presence of calcium-binding proteins. Biol Psychiatry. 52: 708-715.
5. Beierlein M, Gibson JR, Connos BW. 2003. Two dynamically distinct inhibitory networks in layer 4 of the neocortex. J Neurophysiol. 90: 2987-3000.
6. Cauli B, Audinat E, Lambolez B, Angulo MC, Ropert N, Tsuzuki K, Hestrin S, Rossier J. 1997. Molecular and physiological diversity of cortical nonpyramidal cells. J Neurosci. 17: 3894-3906.
7. Chattopadhyaya B, Cristo GD, Higashiyama H, Knott GW, Kuhlman SJ. 2004. Experience and activity-dependent maturation of perisomatic GABAergic innervation in primary visual cortex during a postnatal critical period. J Neurosci. 24: 9598-9611.
8. Constantinidis C, Williams GV, Goldman-Rakic PS. 2002. A role for inhibition in shaping the temporal flow of information in prefrontal cortex. Nat Neurosci. 5: 175-180.
9. Cruikshank SJ, Lewis TJ, Connors BW. 2007. Synaptic basis for intense thalamocortical activation of feedforward inhibitory cells in neocortex. Nat Neurosci. 10: 462-468.
10. El-Faddagh M, Laucht M, Maras A, Vöhringer L, Schmidt MH. 2004. Association of dopamine D4 receptor (DRD4) gene with attentiondeficit/ hyperactivity disorder (ADHD) in a high-risk community sample: A longitudinal study from birth to 11 years of age. J Neural Transm. 111: 883-889.
11. Frantseva M, Cui J, Farzan F, Chinta LV, Perez Velazquez JL, Daskalakis ZJ. 2012. Disrupted cortical conductivity in schizophrenia: TMS-EEG Study. Cereb Cortex. 24: 211-221.
12. Galarreta M, Hestrin S. 1999. A network of fast-spiking cells in the neocortex connected by electrical synapses. Nature. 402: 72-75.
13. Geiger JR, Melcher T, Koh DS, Sakmann B, Seeburg PH, Jonas P, Monyer H. 1995. Relative abundance of subunit mRNAs determines gating and Ca2+ permeability of AMPA receptors in principal neurons and interneurons in rat CNS. Neuron. 15: 193-204.
14. Gibson JR, Huber KM, Sudhof TC. 2009. Neuroligin-2 deletion selectively decreases inhibitory synaptic transmission originating from fast-spiking but not from somatostatin-positive interneurons. J Neurosci. 29: 13883-13897.
15. Graziane NM, Yuen EY, Yan Z. 2009. Dopamine D4 receptors regulate GABAA receptor trafficking via an actin/cofilin/myosin-dependent mechanism. J Biol Chem. 284: 8329-8336.
16. Hashimoto T, Volk DW, Eggan SM, Mirnics K, Pierri JN, Sun Z, Sampson AR, Lewis DA. 2003. Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. J Neurosci. 23: 6315-6326.
17. Hendry SH, Schwark HD, Jones EG, Yan J. 1987. Numbers and proportions of GABA-immunoreactive neurons in different areas of monkey cerebral cortex. J Neurosci. 7: 1503-1519.
18. Hestrin S. 1993. Different glutamate receptor channels mediate fast excitatory synaptic currents in inhibitory and excitatory cortical neurons. Neuron. 11: 1083-1091.
19. Howard MW, Rizzuto DS, Caplan JB, Madsen JR, Lisman J, Aschenbrenner-Scheibe R, Schulze-Bonhage A, Kahana MJ. 2003. Gamma oscillations correlate with working memory load in humans. Cereb Cortex. 13: 1369-1374.
20. Javitt DC, Zukin SR. 1991. Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry. 148: 1301-1308.
21. Jentsch JD, Roth RH. 1999. The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology. 20: 201-225.
22. Jentsch JD, Tran A, Le D, Youngren KD, Roth RH. 1997. Subchronic phencyclidine administration reduces mesoprefrontal dopamine utilization and impairs prefrontal cortical-dependent cognition in the rat. Neuropsychopharmacology. 17: 92-99.
23. Jentsch JD, Tran A, Taylor JR, Roth RH. 1998. Prefrontal cortical involvement in phencyclidine-induced activation of the mesolimbic dopamine system: behavioral and neurochemical evidence. Psychopharmacology (Berl). 138: 89-95.
24. Kapur S, Remington G. 2001. Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia. Annu Rev Med. 52: 503-517.
25. Kawaguchi Y. 1995. Physiological subgroups of nonpyramidal cells with specific morphological characteristic in layer 2/3 of rat frontal cortex. J Neurosci. 15: 2638-2655.
26. Kawaguchi Y, Kubota Y. 1993. Correlation of physiological subgroupings of nonpyramidal cells with parvalbumin-and calbindinD28k-immunoreactive neurons in layer V of rat frontal cortex. J Neurophysiol. 70: 387-396.
27. Kawaguchi Y, Kubota Y. 1997. GABAergic cell subtypes and their synaptic connections in rat frontal cortex. Creb Cortex. 7: 476-486.
28. Kawaguchi Y, Kubota Y. 1998. Neurochemical features and synaptic connections of large physiologically-identified GABAergic cells in the rat frontal cortex. Neuroscience. 85: 677-701.
29. Kruglikov I, Rudy B. 2008. Perisomatic GABA release and thalamocortical integration onto neocortical excitatory cells are regulated by neuromodulators. Neuron. 58: 911-924.
30. LaHoste GJ, Swanson JM, Wigal SB, Glabe C, Wigal T, King N, Kennedy JL. 1996. Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Mol Psychiatry. 1: 121-124.
31. Levitt P, Eagleson KL, Powell EM. 2004. Regulation of neocortical interneuron development and the implications for neurodevelopmental disorders. Trends Neurosci. 27: 400-406.
32. Lewis DA, Curley AA, Glausier JR, Volk DW. 2012. Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia. Trends Neurosci. 35: 57-67.
33. Lewis DA, Fish KN, Arion D, Gonzalez-Burgos G. 2011. Perisomatic inhibition and cortical circuit dysfunction in schizophrenia. Curr Opin Neurobiol. 21: 866-872.
34. Lewis DA, Hashimoto T, Volk DW. 2005. Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci. 6: 312-324.
35. Li D, Sham PC, Owen MJ, He L. 2006. Meta-analysis shows significant association between dopamine system genes and attention deficit hyperactivity disorder (ADHD). Hum Mol Genet. 15: 2276-2284.
36. Maffei A, Nelson SB, Turigiano GG. 2004. Selective reconfiguration of layer 4 visual cortical circuitry by visual deprivation. Nat Neurosci. 7: 1353-1359.
37. Maffei A, Turigiano GG. 2008. Multiple modes of network homeostasis in visual cortical layer 2/3. J Neurosci. 28: 4377-4384.
38. Markram H, Toledo-Rodriguez M, Wang Y, Gupta A, Silberberg G, Wu C. 2004. Interneurons of the neocortical inhibitory system. Nat Rev Neurosci. 5: 793-807.
39. McBain CJ, Fisahn A. 2001. Interneurons unbound. Nat Rev Neurosci. 2: 11-23.
40. Moghaddam B, Adams BW. 1998. Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats. Science. 281: 1349-1352.
41. Mrzljak L, Bergson C, Pappy M, Huff R, Levenson R, Goldman-Rakic PS. 1996. Localization of dopamine D4 receptors in GABAergic neurons of the primate brain. Nature. 381: 245-248.
42. Okaty BW, Miller MN, Sugino K, Hempel CM, Nelson SB. 2009. Transcriptional and electrophysiological maturation of neocortical fast-spiking GABAergic interneurons. J Neurosci. 29: 7040-7052.
43. Pillai G, Brown NA, McAllister G, Milligan G, Seabrook GR. 1998. Human D2 and D4 dopamine receptors couple through betagamma G-protein subunits to inwardly rectifying K+ channels (GIRK1) in a Xenopus oocyte expression system: selective antagonism by L-741, 626 and L-745, 870 respectively. Neuropharmacology. 37: 983-987.
44. Ramanathan S, Tkatch T, Atherton JF, Wilson CJ, Bevan MD. 2008. D2-like dopamine receptors modulate SKCa channel function in subthalamic nucleus neurons through inhibition of Cav2. 2 channels. J Neurophysiol. 99: 442-459.
45. Rao SG, Williams GV, Goldman-Rakic PS. 2000. Destruction and creation of spatial tuning by disinhibition: GABA(A) blockade of prefrontal cortical neurons engaged by working memory. J Neurosci. 20: 485-494.
46. Rowe DC, Stever C, Giedinghagen LN, Gard JM, Cleveland HH, Terris ST, Mohr JH, Sherman S, Abramowitz A, Waldman ID. 1998. Dopamine DRD4 receptor polymorphism and attention deficit hyperactivity disorder. Mol Psychiatry. 3: 419-426.
47. Rubinstein M, Cepeda C, Hurst RS, Flores-Hernandez J, Ariano MA, Falzone TL, Kozell LB, Meshul CK, Bunzow JR, Low MJ et al. 2001. Dopamine D4 receptor-deficient mice display cortical hyperexcitability. J Neurosci. 21: 3756-3763.
48. Rubinstein M, Phillips TJ, Bunzow JR, Falzone TL, Dziewczapolski G, Zhang G, Fang Y, Larson JL, McDougall JA, Chester JA et al. 1997. Mice lacking dopamine D4 receptors are supersensitive to ethanol, cocaine, and methamphetamine. Cell. 90: 991-1001.
49. Sanchez-Vives MV, McCormick DA. 2000. Cellular and network mechanisms of rhythmic recurrent activity in neocortex. Nat Neurosci. 3: 1027-1034.
50. Sawaguchi T, Goldman-Rakic PS. 1991. D1 dopamine receptors in prefrontal cortex: involvement in working memory. Science. 251: 947-950.
51. Spencer KM, Nestor PG, Niznikiewicz MA, Salisbury DF, Shenton ME, McCarley RW. 2003. Abnormal neural synchrony in schizophrenia. J Neurosci. 23: 7407-7411.
52. Tallon-Baudry C, Bertrand O, Peronnet F, Pernier J. 1998. Induced gamma-band activity during the delay of a visual short-term memory task in humans. J Neurosci. 18: 4244-4254.
53. Torrey EF, Barci BM, Webster MJ, Bartko JJ, Meador-Woodruff JH, Knable MB. 2005. Neurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains. Biol Psychiatry. 57: 252-260.
54. Uhlhaas PJ, Singer W. 2006. Neural synchrony in brain disorders: relevance for cognitive dysfunctions and pathophysiology. Neuron. 52: 155-168.
55. Van Tol HH, Bunzow JR, Guan HC, Sunahara RK, Seeman P, Niznik HB, Civelli O. 1991. Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature. 350: 610-614.
56. Vijayraghavan S, Wang M, Birnbaum SG, Williams GV, Arnsten AF. 2007. Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory. Nat Neurosci. 10: 376-384.
57. Volk DW, Austin MC, Pierri JN, Sampson AR, Lewis DA. 2000. Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia. Arch Gen Psychiatry. 57: 237-245.
58. Volk DW, Pierri JN, Fritschy JM, Auh S, Sampson AR, Lewis DA. 2002. Reciprocal alterations in pre-and postsynaptic inhibitory markers at chandelier cell inputs to pyramidal neurons in schizophrenia. Cereb Cortex. 12: 1063-1070.
59. Walsh CA, Morrow EM, Rubenstein JL. 2008. Autism and brain development. Cell. 135: 396-400.
60. Wang M, Vijayraghavan S, Goldman-Rakic PS. 2004. Selective D2 receptor actions on the functional circuitry of working memory. Science. 303: 853-856.
61. Wang X, Gu Z, Zhong P, Chen G, Feng J, Yan Z. 2006. Aberrant regulation of NMDA receptors by dopamine D4 signaling in rats after phencyclidine exposure. Mol Cell Neurosci. 31: 15-25.
62. Wang X, Zhong P, Gu Z, Yan Z. 2003. Regulation of NMDA receptors by dopamine D4 signaling in prefrontal cortex. J Neurosci. 23: 9852-9861.
63. Wang X, Zhong P, Yan Z. 2002. Dopamine D4 receptors modulate GABAergic signaling in pyramidal neurons of prefrontal cortex. J Neurosci. 22: 9185-9193.
64. Wedzony K, Chocyk A, Mackowiak M, Fijal K, Czyrak A. 2000. Cortical localization of dopamine D4 receptors in the rat brain-immunocytochemical study. J Physiol Pharmacol. 51: 205-221.
65. Wilke RA, Hsu SF, Jackson MB. 1998. Dopamine D4 receptor mediated inhibition of potassium current in neurohypophysial nerve terminals. J Pharmacol Exp Ther. 284: 542-548.
66. Williams GV, Goldman-Rakic PS. 1995. Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. Nature. 376: 572-575.
67. Woo TU, Whitehead RE, Melchitzky DS, Lewis DA. 1998. A subclass of prefrontal gamma-aminobutyric acid axon terminals are selectively altered in schizophrenia. Proc Natl Acad Sci USA. 95: 5341-5346.
68. Yang CR, Seamans JK, Gorlova N. 1996. Electrophysiological and morphological properties of layers V-VI principal cells in rat prefrontal cortex in Vitro. J Neurosci. 16: 1904-1921.
69. Yuen EY, Yan Z. 2011. Cellular mechanisms for dopamine D4 receptorinduced homeostatic regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors. J Biol Chem. 286: 24957-24965.
70. Yuen EY, Yan Z. 2009. Dopamine D4 receptors regulate AMPA receptor trafficking and glutamatergic transmission in GABAergic interneurons of prefrontal cortex. J Neurosci. 29: 550-562.
71. Yuen EY, Zhong P, Yan Z. 2010. Homeostatic regulation of glutamatergic transmission by dopamine D4 receptors. Proc Natl Acad Sci USA. 107: 22308-22313.
72. Zhong P, Gu Z, Wang X, Jiang H, Feng J, Yan Z. 2003. Impaired modulation of GABAergic transmission by muscarinic receptors in a mouse transgenic model of Alzheimer's disease. J Biol Chem. 278: 26888-26896.